Xcell Therapeutics, Inc. (373110) Price & Analysis

― Followers

373110 Stock Chart & Stats

₩1089.00

-₩6.00(-0.55%)

Jul 31, 2026

―

Day’s Range― - ―

52-Week Range₩1,009.00 - ₩3,588.34

Previous CloseN/A

VolumeN/A

Average Volume (3M)93.28K

Market Cap

₩18.94B

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.28

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding17,294,394

10 Day Avg. Volume50,533

30 Day Avg. Volume93,279

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)40,214.19

Revenue Forecast (FY)₩17.47T

373110 FAQ

What was Xcell Therapeutics, Inc.’s price range in the past 12 months?

Xcell Therapeutics, Inc. lowest stock price was ₩1009.00 and its highest was ₩3588.34 in the past 12 months.

What is Xcell Therapeutics, Inc.’s market cap?

Xcell Therapeutics, Inc.’s market cap is ₩18.94B.

When is Xcell Therapeutics, Inc.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Xcell Therapeutics, Inc.’s earnings last quarter?

Xcell Therapeutics, Inc. released its earnings results on May 15, 2026. The company reported -₩169.378 earnings per share for the quarter, missing the consensus estimate of N/A by -₩169.378.

Is Xcell Therapeutics, Inc. overvalued?

According to Wall Street analysts Xcell Therapeutics, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Xcell Therapeutics, Inc. pay dividends?

Xcell Therapeutics, Inc. does not currently pay dividends.

What is Xcell Therapeutics, Inc.’s EPS estimate?

Xcell Therapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Xcell Therapeutics, Inc. have?

Xcell Therapeutics, Inc. has 17,294,394 shares outstanding.

What happened to Xcell Therapeutics, Inc.’s price movement after its last earnings report?

Xcell Therapeutics, Inc. reported an EPS of -₩169.378 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.685%.

Which hedge fund is a major shareholder of Xcell Therapeutics, Inc.?

Currently, no hedge funds are holding shares in KR:373110

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology